SELLAS Life Sciences Group, Inc.
(NASDAQ: SLS)

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

3.790 -

-0.175 (-4.41%)
Range 3.755 - 3.970   (5.73%)
Open 3.970
Previous Close 3.965
Bid Price 3.780
Bid Volume 2,942
Ask Price 3.790
Ask Volume 1,007
Volume 2,805,338
Value 7,816,501
Remark -
Delayed prices. Updated at 29 Jan 2026 23:56.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis